Keywords: clarification, fda, tykerb, approval, story, published, on-line

Clarification to FDA's Tykerb approval

Article | 26 March 2007

Print This

In a story published on-line on March 14, we incorrectly stated that Genentech is the US partner for Roche's Xeloda (capecitabine). ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in